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12(S)-hydroxy-S,8,10,14-eicosatetraenoic acid (12(S)-HETE) enhances tumor cell adhesion to cndothelial cells [Honn et al. (1988) Proc. Sot. Exp. 
Biol, Med, 189, 130-1351. The effect is correlated to surface expression of an intcgrin receptor, GpIIb/IIIa. Hen, we describe vidence for 
high-affinity binding of 12(?i’)-HETE to Lewis lung carcinoma cells. Scatchard plot analyses indicated a single slnss of sites with apparent Kd and 
B_ values ofO& nM and 66,000 sites per cell, respectively. Competition cxperimcnts with unlabeled compounds shod d thnt the binding was 
reversible and saturable as well as stereo- and regiospecific, The 12(S)-HETE binding, demonstrated here, might be an important step in a series 
of events controlling surface expression of inlcgrin receptors. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Lipoxygcnases catalyze reactions between O?. and PO,- 
lyunsaturated fatty acids containing 1,4-&,&-pen- 
tadiene structures (recently reviewed in [ 11). Structurally 
related enzymes occur both in plants and animals [2] 
suggesting that they catalyze reactions of fundamental 
biological importance. Mammalian arachidonate S-li- 
poxygenase participates in lea’nutriene bicsynthesis [3] 
and consequently plays an important role in allergy and 
inflammation. The functions of animal 12. and 15.lipo- 
xygenases are less well understood. Reactions catalyzed 
by 15lipoxygenase seem to be involved in the 
programmed isappearance of mitochondria during re- 
ticulocyte maturation [2,4] and in modifying LDL prior 
to lipoprotein uptake by macrophages during foam cell 
formation [2,53. Recently, it has been suggested that 
12.lipoxygenase products participate in the regulation 
of the surface xpression of the integrin receptor GPIIb/ 
IIIa on carcinoma nd melanoma cells [6]. The reported 
stereo- and regio-specificity of this effect suggested to 
us that 1ZHETE might interact with a specific binding 
site. The purpose of the present investigation was to 
determine if such binding sites could be demonstrated 
in Lewis lung carcinoma cells. 
?. I. Cl~emicuis 
l?(S)-I-lydroxy-[5,6,8,9,1 1 2,14,15(~~)-3~i]-eicosatctraenoic acid 
(spccilic activity 178 or 103 Cilmmol) was purchased from New En- 
gland Nuclear and Amcrsham, respectively. S(S)-HETE, 12(s)- 
HETE. 12(A)-HETE, 15(S)-HETE, 5(5’),l?(S)-diHETE, 6-rrwls- 
LTB,, 6.rrrms-12-epi-LTB, and 13(S)-MODE were purchased from 
Caynran Chemicals, Ann Arbor, Ml. Leukotriene B1 was kindly pro- 
vided by Dr. A. Ford-Hutchinson, Merck Frosst, Pointe-Claire. 
Dorval, Qucbcc, Canada. Altcrnadvely, 12(S)-hydroxy-5,8,10,14-ei- 
cosatetraenoic acid (12(S)-HETE) was prepared from arachidonic 
acid using bovine platelets ns enzyme source [7]. Blood, collected at 
slaughter in acid citrate dextrose (ACD), was ccntrifugcd for 4 min at 
1,500 x g, 4OC. The supernatant was recenlrifuged at I.000 xg for 20 
min, Arachidonic acid was incubated with the platelets as described 
[7]. The purification of 12(S)-HETE was carried out by chromatogra- 
phy on a column of I g SilicAR CC-4 (Mallinckrodt). The sample was 
applied to the column in diethylctherlheptane ( I :9, v/v) and eluted with 
20 ml diethylether/heptanc (I : 1, v/v). 11 was further purified by rcverse- 
phase HPLC on C,,-Nucleosil using methanoVH,O/acetic a id 
(78:22:0.01, by volume; solvent A) as mobile phase al a flow rote of 
I mUmin. 
2,2. CCN cl.hm 
Lewis lung carcinoma cells (LLC) were a generous gift from Dr. 
Gilbert Vaes (Labomtoire de Chimic Physiologique, Universitd de 
Louvain, Brussels, Belgium). The cells were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 100 W/ml 
penicillin, IOO~g/ml streptomycin and 10% (v/v) heat-inactivated (30 
min at 56OC) fetal calf serum (Gibco) at 37OC in a hum&d atmos- 
phere containing 10% (v/v) CO,. Cultures were passaged by USC of0.54 
mM EDTA in an isotonically buffered saline. Cells were not used 
beyond 20 consecutive passages in vitro. 
Correspondecxr address: S. Hammarstrbm. Department of Cell Biol- 
ogy, Faculty of Health Sciences, Link&ping University, S-5Bl 85 
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decadienoic acid; LLC, Lewis IuFg carcinoma; LTBJ, leukotriene B1. 
Published by EIswicr Scictm Publishers B. V. 
2.3. Binding assuy 
LLC cells wcrc grown on 2Cmultiwell cullurc lrays (Flow Labo- 
ratories) for 24-48 h before binding experiments were performed. The 
cultures were wasbed Lwice with phosphate-burercd sa:inc (PBS; 
before incubation with 12(S)-[‘H]HETE (0.1 nM, except for Scatchard 
analyses) in Dulbccco’s modified Eagle’s medium (DMEM) buffered 
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with 15 mM HEPES and supplemcntcd with 150 IU/ml penicillin and 
155 bdrnl streptomycin. The incubation volume of each well was 450 
,U and incubations were performed at 4°C with gentle shaking. The 
binding reactions were terminated by washing the cells with ice-cold 
incubation but& 4 times. After solubilitation of the cells with 0.1 M 
NaOH, the cellbound radioactivity wus measured by liquid scintilla- 
tion spectrometry. Non-specific binding was deicrmincd in the pres- 
ence of 150 nM unlabeled II(S)-HETE, Specilic binding was defined 
as the difference between the totul binding of I?(S)$H]HETE and 
non-specific binding. All data are expressed as mean values from 
triplicate analyses. The time course of the binding reaction was 
analyzed by incubating 5.1 nM 12(S)-[‘HIHETE with LLC cells in the 
presence or absence of unlabeled 12(S)-HETE (105 nM) for various 
lengths of time, The reversibility was determined by adding a thousand 
fold excess of unlabeled I21.Y).HETE to all wells after 125 min incuba- 
tion. To calculate binding constari&s at equilibrium. different con- 
centrations of 12(s)-[?H]HETk (5.1-2 nM) were incubated with LLC 
cells for I20 min. Non-specific binding was determined as described 
above. Cell numbers were obtained from parallel wells atIer dctach- 
mcnt by 2.5 g/l trypsin, 2.7 mM EDTA in phosphate-buffered saline 
(PUS) using a haemocytomcter. Linear curve fitting was performed on 
the result according to the least square method and gave A? = 0.94. 
Competition studies were performed by addition of different un- 
labeled compounds in the concentration range 0 to IO-’ M and non- 
specific binding was determined by adding with 100 nM unlabeled 
12(S)-HETE. 
LLC cells in a tissue culture flask were incubated with 0.1 nM 
I?(S)-pH]HETE for 120 min at 4°C in the same buffer as in the other 
experiments, The incubation burer was removed and acidified to pH 
3 by acetic acid before xtraction with dicthylsthcr, The extract was 
analyzed on a C,,-Nuclcosil HPLC column using solvent A at I ml/ 
min. 
3. RESULTS 
3.1. Metabolic stability of 12(S)-HETE irf the bindir~g 
assuy 
When ~~(.$)s?-[~H]HETE was incubated with LLC cells 
for 120 min at 4OC about 90% of the radioactivity re- 
covered from the incubation buffer had the same reten- 
tion time on HPLC as 12HETE. 
Figure 1A shows a time course experiment of 12(s)- 
13H]HETE binding to LLC cells at 4OC. Equilibrium 
was reached within 90 min after the addition of ligand. 
A standard incubation time of 120 min was chosen. In 
Fig. 1B 12(s)-[‘H]HETE was first incubated with LLC 
cells for 120 min, then a thousand-fold excess of un- 
labeled compound was added. The cellbound radioac- 
tivity diminished by 80% within 90 min suggesting that 
12(S;-HETE binding is reversible. The experiments in 
Fig. 1A and II3 were performed on different days and 
using separate batches of cells which explains the varia- 
tion in total binding observed. Fig. 2 shows a Scatchard 
plot [8] obtained after incubating 12(S)-[“H]HETE (O.l- 
2 nM) with LLC cells as described in Section 2. The 
results indicated a single population of binding sites 
with apparent Kd and B,,,, values of 0.44 nM and 66,000 
sites per cell, respectively. 
3.3. SpeciJicity of rhe bbrding reaction 
To examine the specificity of binding, competition 
experiments were performed. LLC cells were incubated 
with 12(S)-[“HIHETE (0.1 nM) in the presence of differ- 
ent concentrations (O-1O’6 M) of structurally related, 
unlabeled compounds. Table I shows the I&, values 
obtained. Two positional isomers of 12(S)-METE, 5(s)- 
HETE and 1 S(S)-HETE, formed from arachidonic acid 
by distinct lipoxygenases, and 13(S)-I-IODE, derived 
from linoleic acid by one type of 12- or 15Jipoxygenase 
[1], gave KS0 values of around 5 x lo-’ M. Unlabeled 
12(S)-HETE, analyzed under the same conditions, had 
an ICsO value of ca. S x lo-’ M. 12(A)-HETE, the 
enantiomer of 12(S)-HETE, did not compete for bind- 
ing even at a concentration of 10V6 M. Thus, the stcreo- 
specificity of binding was greater than the positional 
specificity. Two dihydroxy metabolires of arachidonic 
acid both having a 12(S)-hydroxyl group and in addi- 
tion a S(S)-hydroxyl group, S(S),l2(S)-diHETE and 6- 
Tiliii3 (fiinj TiinG jiiiiii j 
Fig. I, (A) Time course of specific binding of 12(S)-[“HIHETE to LLC-cells. (13) Reversibility of 12(S)-[‘HIHETE binding to LLC-cells, The cells 
were preincubated with 0.1 nM I?(S)-[‘H]HETE at 4OC for 125 min. A l,505-fold excess of unlabeled 12(S)-HETE was then added. 150% 
corresponds to the total amount of bound ligand (1.2 fmol) after 120 min. 
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tr~ns-lZepi-LTB,, also did not compete for binding at 
concentrations up to 10’” M. The effects of LTBl and 
6-fuans-LTB1 were also determined. These two com- 
pounds have 5(s)- and 12(A)-hydroxyl groups. No com- 
petition was observed for 6-rruns-LTB, (It&, > 10m6 M) 
whereas LTB4 at 10v6 M reduced the binding to 64% of 
the initial value. 
4. DISCUSSION 
12.HETE is an important arachidonic acid metabo- 
lite in platelets [9J, epidermis [lo] and brain [ll]. Its 
biological function in these cells and tissues is not well 
understood. It has been suggested that it has pathogen- 
etic importance for psoriasis [10,12]. 12(S)-HETE is 
also synthesized in LLC cells [13]. A correlation has 
been reported between 12(S)-HETE synthesis and 
metastatic ability [14] which might be secondary to in- 
tegrin GpIlb/ Illa mediated tumor cell adhesion to en- 
dothelial cells, subendothelial matrix and fibronectin 
[6]. The high degree of stereospecificity reported for 
these effects suggested to us that binding to a binding 
site for 12(s)- HETE is an early step in a sequence of 
events regulating integrin expression. A binding assay 
was developed and specific binding was demonstrated. 
The characteristics of 12(sl-[3H]HETE binding to LLC 
cells satisfies the criteria for a receptor; the binding is 
specific, reversible, saturable and has high affinity and 
low capacity for the ligand. The apparent dissociation 
constant (&) was 0.44 nM. This means that this binding 
site has a similar or higher affinity for its ligand com- 
pared to other eicosanoid receptors: 15WHETE 
bound to a cloned strain of rat pituitary cells with a & 
of 0.75 nM [15] and 12(S)-HETE bound to squamous 
carcinoma cells with a Kd of 2.6 nM [12]. Two popula- 
tions of receptor sites for LTB4 were reported on poly- 
nuclear leukocytes with dissociation constants of 0.4 
nM and 61 nM, respectively [16]. The dissociation con- 
stant for prostaglandin E, binding to a fraction from 
hypothalamus was 4 .2 nM [17] and for prostaglandin 
D2 binding to synaptic membranes of rat brain 28 nM 
[18]. Prostaglandin Flrr bound to a particular fraction of 
ttd = O.&i nhti 
Bmax = 66OOO/oell 
0 5 10 i5 20 25 
~WWHETEI~W~KI QW 
Fig. 2. Scalchard plot of binding data at equilibrium. 
bovine and ovine corpora lutea with f&s of 50 nM [19] 
and 100 nM [20], respectively. The binding site de- 
scribed here was highly specific for 12(S)-HETE. Table 
I lists the I& values for different competitors. These 
compounds were chosen because they occur naturally 
and are structurally related to 12(S)-HETE. The results 
indicate which parts of the 12 (S)-HETE molecule are 
most important for binding. 13(S)-HODE is also inter- 
esting because ithas antagonistic effects to 12(S)-HETE 
[6]. The binding affinity of the various related com- 
pounds indicated that both the position and the 
stereochemistry of the hydroxyl group are important for 
binding. Furthermore, monohydroxy acids were 
preferred compared to dihydroxy compounds. Among 
the dihydroxy acids LTB4 was a more potent competitor 
than 6-rrarrs-LTB,, 6-r~uas-l2-epi-LTB., and 
S(S),12(S’)diHETE suggesting that the configuration at 
Cl2 is not the only determinant for binding affinity. The 
binding of 12(S)-HETE to Lewis lung carcinoma cells, 
reported here, might be an important step in regulating 
integrin surface expression. Further studies concerning 
the 12(S)-HETE binding site are in progress. 
Table 1 
CompeUion by various lipoxygennsc products on specific binding of 12(S)-HETE to LLC cells 
Compound 
Abbreviated name 
Gl ., 
Syslematic name 
S(S)-HETE 
12(S)-HETE 
1 ‘(@METE 
I S(S)-HETE 
5(5’),12(S)-diHETE 
6.frflfts-LTB, 
G-mm- 1 Bepi-LTB, 
LTB., 
13(S)-HODE 
(G&82, I 12,142).(S(q)-5.hydroxycicosa-6,8,1 I, I4-tetracnoic acid 
(SZ,SZ, lOE, 142).(12(s))-I 2-hydroxyeicosa-5,8,10,14-tetracnoic id 
(SZ,SZ, IOE,142)-( 12(&)-l 2-hydroxycicosa-5,8,lO,l4-tetr~enoic acid 
(52,82,1 lZ,I 3E)-(15(S))-I5-hydroxycicosa-5,8,11,13-tctr~enoic acid 
(6E.8Z.lOE,l4Z)-(S(~).12(~)-5,l2~ihydro~yei~~a-6,8~ IO,IGtctrdcnoic acid 
(G~.S~,lO~,l4Z)~S(s),l2(it))-5,12~ibydro~y~i~sa-6,8,I~,~~tcti~c~oic add 
(GE,8E,10E,142)-(5(5),12(S))-5,12-dihydroxyeicosa-6,8,10,14-tetraenoic acid 
(6Z,8E,l0E,14Z)-(5(~,12(~))-5,12-dihydro%yci~~-6,8,10,1~tet~enoic acid 
192.1 lBI-~131~)-13-hvdroxvoEtadecP-9.1 I-dienoic acid 
ca. 5 x IO-’ M 
ca. 5 x IO-” M 
z- 10-O M 
ca. 5 x lo-’ M 
x- IO” M 
x- !P &A 1.. 
> IO+ M 
> lO+‘M 
ca. 5 x IO-’ M 
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